Evidence into Practice (T2/T3) Working Group

450 jets


The Evidence into Practice (T2/T3) Working Group is chaired by Associate Professor Tim Shaw and has an important advisory role with respect to the T2/T3 translational research program of Sydney Catalyst. Other members of the T2/T3 Working Group include the immediate past Chair Professor Jane Young, Professor Phyllis Butow, Professor Kate White, Associate Professor Sallie-Anne Pearson, Professor Jane Phillips and the Sydney Catalyst T2/T3 Research fellow Dr Nicole Rankin.


Read more about some of our Evidence into Practice (T2/T3) Working Group members...


Associate Professor Tim Shaw BSc (Hons) PhD

Tim Shaw 200pxwInvolvement in Sydney Catalyst: Tim is a member of the Scientific Advisory Council of Sydney Catalyst and chairs the Evidence into Practice (T2/T3) Working Group. Working with the Sydney Catalyst T2/T3 Translational Fellow and the Sydney Catalyst Education Fellow Tim is taking a leading role in developing Sydney Catalyst's implementation research and education activities.

Background: Tim is Director of the Workforce Education and Development Group in the Faculty of Medicine at The University of Sydney. He has managed a number of substantial Health workforce educational research and development projects in Australia including: the development of the Australian National Patient Safety Education Framework; Basic Surgical training online for the Royal Australasian College of Surgeons; the development of the Cancer Learning Knowledge portal for the Commonwealth Government; the development of the ISQUA Knowledge Portal for the International Society for Quality in Healthcare; and the use of new technologies to improve event reporting amongst junior doctors at Brigham and Mass General Hospitals in Boston. He was a contributor to the WHO Patient Safety Curriculum Framework for Medical Schools and the Patient Safety Education Project (PSEP) in the United States.

He was a visiting Professor at Harvard Medical School for 12 months in 2008/9 during which time he developed new methodologies for the dissemination of evidence based medicine through online learning. He has also acted as an advisor and consultant to the Institute for Healthcare Improvement Open School Project, Partners Harvard Medical International and the Joint Commission in the United States.

Research interests: Tim's research focuses on knowledge dissemination and transfer and flexible learning.


Professor Phyllis Butow PhD MPH MClinPsych BA(Hons)DipEd

Phyllis butow 400px

Involvement in Sydney Catalyst: Phyllis is a member of the Sydney Catalyst Governing Council, as well as the Evidence into Practice (T2/T3) Working Group. She is also one of the inaugural chief investigator recipients of Sydney Catalyst pilot and seed funding for her project titled: 'Translating evidence into practice; implementing clinical pathways to relieve psychological distress and improve wellbeing for cancer patients'.

Background: Phyllis has worked for over 20 years in the area of Psycho-Oncology and has developed an international reputation in this and the area of health communication. She is currently Professor and NHMRC Senior Principal Research Fellow in the School of Psychology, University of Sydney. She directs the Centre for Medical Psychology and Evidence-based Decision-making (CeMPED), and chairs the Australian Psycho-Oncology Co-operative Trials Group. She has taken a leading role in Australia in promoting and facilitating communication skills training for Oncology health professionals.

Research interests: Much of Phyllis's research concerns the impact of communication strategies on doctor and patient outcomes, and this has been translated into a number of communication skills modules for cancer health professions. Prof Butow has over 300 publications in peer reviewed journals, most of which relate to psychological issues in cancer


Associate Professor Sallie-Anne Pearson BSc (Hons) PhD  

Sallie Pearson 200pxwInvolvement in Sydney Catalyst: Evidence into Practice (T2/T3) Working Group member

Background: Sallie is a health service researcher and behavioural scientist with more than 15 years experience in quality use of medicines research.  She is the head of the Pharmacoepidemiology and Pharmaceutical Policy Research Group, Faculty of Pharmacy, The University of Sydney and has had a specific interest in cancer care since she established her research program in 2006. Sallie is currently a Cancer Institute Career Development Fellow and chief investigator on grants awarded from the NHMRC, Cancer Australia and the Cancer Institute NSW. Sallie sits on a number of national and state committees including the Drug Utilisation Sub-Committee of the Pharmaceutical Benefits Advisory Committee and is the Chair of the NSW Population and Health Service Research Ethics Committee.

Research interests: Sallie's research interests include prescriber behaviour change, post-market surveillance of medicines and evaluating the impact of pharmaceutical policy interventions. She leads a large program of work evaluating the use and impact of cancer medicines in routine clinical care using linked secondary health data. In addition she has undertaken a range of studies including systematic reviews, quantitative and qualitative research to better understand the way in which oncology clinicians use web-based guidelines to support prescribing decisions at the point of care.


Professor Jane Phillips BSc (Nur) RN PhD

Jane Phillips

Involvement in Sydney Catalyst: Jane is a Sydney Catalyst Evidence into Practice (T2/T3) Working Group member involved in the development of the T2/T3 Flagship program

Background: Jane is the inaugural Professor of Palliative Nursing at the University of Notre Dame, Australia and attached to The Cunningham Centre for Palliative Care, based at Sacred Heart Hospice, St Vincent's, Sydney and co-leads the Palliative Care Clinical Trials Unit at Sacred Heart. Jane has an in-depth understanding of cancer and palliative care, experience in delivering best evidenced based nursing care across diverse settings, including rural and regional Australia, and considerable experience in leading and evaluating complex health service reforms.

She has worked extensively as a registered nurse in rural and urban palliative care settings across Australia, including 10 years as a Palliative Care Clinical Nurse Consultant in Regional NSW. From 2004-2006 she coordinated the Mid North Coast Division of General Practice Palliative Care Project a Commonwealth initiative focused on strengthening partnerships to improve palliative care outcomes for patients and their families in rural Australia. In 2005 she completed the "Program in Palliative Care Education and Practice" at Harvard Medical School. From 2007-mid 2009, Jane was the Program Manager, Education and Service Development Section with Cancer Australia.

Her doctoral study was completed in 2008 and focused on 'Navigating a palliative approach in residential aged care using a population based approach'. This action research project has subsequently informed the delivery of end-of-life care in the Australian residential aged care sector.

A link to her publications is here

Research interests: Jane's academic and research interests include: translational research, implementation and dissemination research, chronic disease management, aged palliative care and population based palliative care delivery. She is currently undertaking studies to: evaluate non-pharmacological interventions to improve breathlessness; improve care outcomes for older people with cancer; improve end-of-life symptom management for older people in residential aged care; and translational research in the areas of pain and other symptoms, models of care, and bereavement care.


Dr Nicole Rankin BA (Hons) MSc PhD

Nicole 200pxw3

Involvement in Sydney Catalyst: Nicole is the translational research fellow for T2/T3 research at Sydney Catalyst.  In collaboration with the Evidence into Practice (T2/T3) Working Group and Sydney Catalyst members, Nicole is directly involved in the strategic development of the T2/T3 program and the design of research projects. She is a lead investigator for the T2-3 Flagship in Lung Cancer. Nicole is also on the Sydney Catalyst Scientific Advisory Committee.

Background: Nicole has more than 15 years experience working in cancer control, primarily in psychosocial and behavioural aspects of patient care.  She has undergraduate qualifications in Psychology and Sociology and completed her PhD in 2000 in the discipline of Behavioural Science in Relation to Medicine at the University of Newcastle. She was manager of the Psychosocial Program at the National Breast Cancer Centre (2000-2003), manager of the Patient Support Program at the Cancer Institute NSW (2004-2006) and the Executive Director of PoCoG (the Psycho-oncology Cooperative Research Group) from 2006-2009. She has also held research positions at the University of Wollongong (2009-2010) and Relationships Australia (2011).

Research interests: Nicole's research interests are in the implementation of evidence into cancer practice and policy. She has significantly contributed to the development and implementation of psychosocial clinical practice guidelines and has led implementation and evaluation programs in psychosocial oncology, specialist breast cancer nursing and models of peer support. Nicole's current research interests are in lung cancer, head and neck cancer and psychosocial clinical pathways.  


Professor Kate White RN, PhD, MN, CertOnc CertPall, FRCNA FCN (NSW)

Kate White 400pxw

Involvement in Sydney Catalyst: Professor Kate White is a member of Sydney Catalyst, a Evidence into Practice (T2/T3) Working Group member and member of the Scholarships Working Group.  Kate's focus within Sydney Catalyst is on knowledge translation in supportive care.

Background: Kate has over 20 years of experience in clinical practice, education and research in cancer care. As the inaugural Chair of Cancer Nursing and Director of the Cancer Nursing Research Unit (CNRU), located at Royal Prince Alfred Hospital, she mentors cancer nurse clinicians in clinical research, translation of evidence into practice, and develops and evaluates models of health care delivery with a focus on nurse-led roles.

Kate has been invited to participate in the development and evaluation of a number of national evidence-based guidelines, including the NHMRC-endorsed Psychosocial Clinical Practice Guidelines. She has served as a guideline reviewer for the NHMRC (Acute pain management: scientific evidence), member of the Management of menopausal symptoms & fertility issues in younger women with breast cancer Working Group and is a member of the Cancer Counil NSW Research Committee.  She has led education developments in the area of palliative care, cancer and haematology  nursing, and clinical trials practice.

Research interests: Kate's research interests are in improving supportive care for patients with cancer, particularly through nurse-led interventions, and enhancing the skills and practice of cancer and palliative care clinicians through the development and evaluation of formal and continuing education programs. She is currently leading a major program of research into evidence based supportive care in cancer. In 2011, Kate was awarded the prestigious Churchill Fellowship to visit the Royal Marsden Hospital in London to examine approaches to addressing sexual dysfunction in cancer patients. She is currently working on adapting this model for the Australian context. 


Professor Jane Young MBBS MPH PhD FAFPHM

Jane Young 200pxw

Involvement in Sydney Catalyst: Jane sits on the Scientific Advisory Committee of Sydney Catalyst and is the immediate past Chair of the Evidence into Practice (T2/T3) Working Group. She is also one of the inaugural chief investigator recipients of Sydney Catalyst pilot and seed funding for her project titled: 'Quantifying evidence‐practice gaps in clinical follow‐up for people with rectal cancer in NSW; a population‐based study.'

Background: Jane is an epidemiologist with a medical background and specialist training as a public health physician. She holds the Cancer Institute NSW Chair in Cancer Epidemiology at the University of Sydney and is the Scientific Director of the Cancer Institute NSW as part of this role. She has been the Executive Director of SOuRCe (Surgical Outcomes Research Centre) which is based at Royal Prince Alfred Hospital, Sydney, since its inception in 2002. Jane is a health services researcher with major interests in the delivery and outcomes of cancer care, surgical outcomes and the use of data to improve service performance. She is a member of the Effective Practice and Organisation of Care (EPOC) Cochrane Review Group and is a co-author of the Cochrane Review of audit and feedback to improve professional practice and health outcomes. She is the Principal Investigator of several randomized trials, including trials of a novel, nurse-delivered, telephone-based intervention to improve quality of life for post-operative patients with cancer and their families (the CONNECT Program). A list of her publications can be found here

Research interests: Jane has major research interests in the generation and synthesis of evidence for the effectiveness of health care interventions, the uptake of evidence-based practice, health outcomes studies, record linkage studies and the use of data to improve health service performance.


Other Evidence into Practice (T2/T3) Working Group members...